<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_LZU-CHINA_Futurework skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:LZU-CHINA/Futurework</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="bg-wetlab"><SECTION class="generic-banner-safety relative"><HEADER class="default-header"><NAV class="navbar navbar-expand-lg  navbar-light"><DIV class="container"><DIV class="collapse navbar-collapse justify-content-end align-items-center" id="navbarSupportedContent"><UL class="navbar-nav"><LI><A href="https://2018.igem.org/Team:LZU-CHINA">Home</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2018.igem.org/Team:LZU-CHINA/Team" id="1" data-toggle="dropdown">Team</A><DIV class="dropdown-menu"><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Team">Team</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Attributions">Attribution</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Collaborations">collaborations</A></DIV></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2018.igem.org/Team:LZU-CHINA/Description" id="2" data-toggle="dropdown">Project</A><DIV class="dropdown-menu"><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Description">Description</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Design">Design</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Parts">part</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Experiments">experiments</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Safety">safety</A></DIV></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2018.igem.org/Team:LZU-CHINA/Results" id="3" data-toggle="dropdown">wet lab</A><DIV class="dropdown-menu"><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Results">result</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Futurework">future work</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/InterLab">interlab</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Notebook">notebook</A></DIV></LI><LI><A href="https://2018.igem.org/Team:LZU-CHINA/Model">dry lab</A></LI><LI class="dropdown"><A class="dropdown-toggle" href="https://2018.igem.org/Team:LZU-CHINA/Human_Practices" id="4" data-toggle="dropdown">HP</A><DIV class="dropdown-menu"><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Human_Practices">intergrated hp</A><A class="dropdown-item" href="https://2018.igem.org/Team:LZU-CHINA/Public_Engagement">public engagement</A></DIV></LI></UL></DIV></DIV></NAV></HEADER><DIV class="container" style="height: 100%"><DIV class="row height align-items-center justify-content-center" style="height: 90%"><DIV class="col-lg-10"><DIV class="generic-banner-content"><H2 class="text-white">Future Work</H2></DIV></DIV></DIV></DIV></SECTION><DIV class="main-wrapper"><DIV class="location"><P class="scroll_top" style="text-align: center;font-size: 16px;">RETURN TOP</P></DIV><SECTION class="about-generic-area pt-100" id="p1"><DIV class="container" style="background: rgb(255,255,255)"><DIV class="col-md-12"><P class="para2" style="font-family: 'Segoe Print';color: darkred">Each huge project requires comparative studies and repeated experiments to verify the results from different aspects, also, a clear and innovational idea is essential. Nowadays, the cellular immunotherapy mainly focus on the antigen and antibody, however, tumor heterogeneity makes the target much more diffcult. So we went in the another direction, the microenvironment of tumor is always different from normal tissue, a low-oxygen and acidic environment. Therefore, we wish to develop the TIL cell, a nature targeting cell in the tumor tissue, which is induced by hypoxia inducible promoter to massively secrete our armed- exosome. As tumor cells have a higher efficiency than normal cells in uptaking exosomes, the target consideration is solved to a certain extent.
								We’ve already finished the test experiments of high yield of exosome, and miRNA function verification. Following is our future work:
							</P><P class="para2">1.	 The activity of tetracycline induced promoter and galactose promoter was verified using the luciferase reporting system.


								2.	 The anti-tumor effect of miR-942-5p/miR-769-5p was further verified through cell biology experiments, and specific regulatory targets of miRNA were explored using molecular biology experiments.


								3.	Obtain the approval of our local ethics committee and the informed consent of patients, and then remove tissue and extract TIL cells during the operation of gastric cancer.


								4.	All modules are constructed on a lentiviral plasmid, and the lentivirus is packaged based on HEK-293T cells.


								5.	 Using lentiviral to transfect TIL cells to construct stable cell lines and animal experiments were conducted with the supervision of the ethics committee. The model of gastric cancer in situ in nude mice was constructed, and the function of our TIL cells was verified by intravenous injection of modified TIL cells.

							</P></DIV></DIV></SECTION><FOOTER class="footer-area section-gap"><DIV class="container"><DIV class="row"><DIV class="col-lg-6 col-md-6 col-sm-6"><DIV class="single-footer-widget"><H6>About Us</H6><P>
									We wish to extend our deepest appreciation to the Lanzhou University, The First Clinical Medical College and School of Life Science for the great support and help in this project
								</P></DIV></DIV><DIV class="col-lg-6 col-md-6 col-sm-6 social-widget"><DIV class="single-footer-widget"><H6>Contact Us</H6><P>E-mail：752786236@qq.com 1098385458@qq.com</P><P>Address：No. 222, Tianshui South Road, chengguan district, Lanzhou City, Gansu Province,730000, P. R. China.</P><P style="font-size:20px;font-family: 'Segoe Script'">We are the walker on the long journey towards science</P><P class="footer-text">Copyright ©2018 iGEM LZU-CHINA Team All rights reserved.</P></DIV></DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>